Recognizing Excellence in Peer Review

ISTH Academy, Faculty / Presenter(s), 286318

The risk of arterial thromboembolic events after cancer diagnosis

ISTH Academy, Babak B. Navi, 286319

Platelet preparation for function testing in the laboratory and clinic: Historical and practical aspects

ISTH Academy, Christian Gachet, 286320

Hemostatic complications associated with ventricular assist devices

ISTH Academy, Thomas Deloughery, 286321

Thrombin generation measurement using the ST Genesia Thrombin Generation System in a cohort of healthy adults: Normal values and variability

ISTH Academy, Anne Angelillo- Scherrer, 286330

#WomenInMedicine: Progress in gender equity at Research and Practice in Thrombosis and Haemostasis

ISTH Academy, Mary Cushman, 286331

Prolonged APTT of unknown etiology: A systematic evaluation of causes and laboratory resource use in an outpatient hemostasis academic unit

ISTH Academy, Erich De Paula, 286332

Direct oral anticoagulants and warfarin for venous thromboembolism treatment: Trends from 2012 to 2017

ISTH Academy, Pamela L. Lutsey, 286333

Alternative trafficking of Weibel‐Palade body proteins in CRISPR/Cas9‐engineered von Willebrand factor–deficient blood outgrowth endothelial cells

ISTH Academy, Ruben Bierings, 286334

Corrigendum

ISTH Academy, Faculty / Presenter(s), 286335

Blood platelets: Circulating mirrors of neurons?

ISTH Academy, Ilaria Canobbio, 286336

Post‐thrombotic syndrome in children: Measurement properties of CAPTSure, a new diagnostic tool

ISTH Academy, Maria Laura Avila, 286337

Thrombosis and hemostasis health in pregnancy: Registries from the International Society on Thrombosis and Haemostasis

ISTH Academy, Maha Othman, 286345

Atrial fibrillation in patients with end‐stage renal disease on hemodialysis: Magnitude of the problem and new approach to oral anticoagulation

ISTH Academy, Oliver Königsbrügge, 286346

Plasma levels of mannose‐binding lectin and future risk of venous thromboembolism

ISTH Academy, Robin Amanda Liang, 286243

Managing sepsis‐associated coagulopathy remains an enigma

ISTH Academy, Jecko Thachil, 286244

Hypothermia‐induced activation of the splenic platelet pool as a risk factor for thrombotic disease in a mouse model

ISTH Academy, Hiroki Tanaka, 286245

Topical tranexamic acid inhibits fibrinolysis more effectively when formulated with self‐propelling particles

ISTH Academy, Amedeo Piazza, 286246

Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD‐VTE patients

ISTH Academy, Sylvia Haas, 286247

Thromboembolism in major joint prosthetic surgery: False or fact

ISTH Academy, Ola E. Dahl, 286248

Clinical and laboratory practice for lupus anticoagulant testing: An International Society of Thrombosis and Haemostasis Scientific and Standardization Committee survey

ISTH Academy, Hannah Cohen, 286249

Definitions, adjudication, and reporting of pulmonary embolism–related death in clinical studies: A systematic review

ISTH Academy, Farrukh Awan, 286250

Platelet‐derived extracellular vesicles released after trauma promote hemostasis and contribute to DVT in mice

ISTH Academy, Matthew Neal, 286251

Trauma‐targeted delivery of tranexamic acid improves hemostasis and survival in rat liver hemorrhage model

ISTH Academy, Anirban Sen Gupta, 286252

Heparin‐induced thrombocytopenia complicating extracorporeal membrane oxygenation support: Review of the literature and alternative anticoagulants

ISTH Academy, Uri Pollak, 286253

The role of a specialist bridging service. A New Zealand prospective study of 600 patients

ISTH Academy, Ruell Jackie, 286254

ISTH news and updates: Join the ISTH today

ISTH Academy, Faculty / Presenter(s), 286255

Toll‐like receptors 2 and 7 mediate coagulation activation and coagulopathy in murine sepsis

ISTH Academy, Wei Chao, 286256

Rivaroxaban pharmacodynamics in healthy volunteers evaluated with thrombin generation and the active protein C system: Modeling and assessing interindividual variability

ISTH Academy, Virginie Siguret-Depasse, 286257

Antiphosphatidylserine/prothrombin complex antibodies as a determinant of prothrombotic plasma fibrin clot properties in patients with antiphospholipid syndrome

ISTH Academy, Anetta Undas, 286258

The potential of serpins for future treatment for haemophilia

ISTH Academy, Josefin Ahnstrom, 286259

What The Neighbors Say

ISTH Academy, Faculty / Presenter(s), 286260

George J. Broze Jr., MD (3 August 1946–19 June 2019)

ISTH Academy, Faculty / Presenter(s), 286261

Engineering a protein Z‐dependent protease inhibitor (ZPI) mutant as a novel antagonist of ZPI anticoagulant function for hemophilia treatment

ISTH Academy, Xin Huang, 286262

Issue Information

ISTH Academy, Faculty / Presenter(s), 286263

Tranexamic acid for trauma: Repackaged and redelivered

ISTH Academy, Keith Neeves, 286264

The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH

ISTH Academy, Tzu-Fei Wang, 286265

Does the Villalta scale capture the essence of postthrombotic syndrome? A qualitative study of patient experience and expert opinion

ISTH Academy, Hilde Skuterud Wik, 286266

Risk assessment models: thromboprophylaxis & VTE recurrence

ISTH Academy, Lara Roberts and Sabine Eichinger, 273714

Inhibitors in hemophilia: Risk factors, biomarkers and other predictors

ISTH Academy, Samantha Gouw and Rolf Carl Ljung, 273713

A non‐circulating pool of factor XI associated with glycosaminoglycans in mice

ISTH Academy, stefan milewczyk, 286213

Physical proximity and functional cooperation of glycoprotein 130 and glycoprotein VI in platelet membrane lipid rafts

ISTH Academy, Isabelle ODIN, 286214

Mice, men, and differences therein

ISTH Academy, Alisa Wolberg, 286215

Professor Helge Stormorken, 1922‐2019

ISTH Academy, Faculty / Presenter(s), 286216

Corrigendum

ISTH Academy, Faculty / Presenter(s), 286217

Risk prediction of recurrent venous thrombosis; where are we now and what can we add?

ISTH Academy, Suzanne Cannegieter, 286218

Recommendations for clinical laboratory testing of activated protein C resistance; communication from the SSC of the ISTH

ISTH Academy, Gary Moore, 286219

No resistance to activated protein C resistance—but choose wisely

ISTH Academy, Rita Selby, 286220

Response to Letter to the Editor submitted by Dr. Wada and Dr. Yamakawa re: Trauma‐induced coagulopathy: The past, present, and future

ISTH Academy, Faculty / Presenter(s), 286221

Sex matters: Practice 5P's when treating young women with venous thromboembolism

ISTH Academy, DARIO ZAZZARO, 286222

Trauma‐induced coagulopathy: The past, present, and future: A comment

ISTH Academy, Gregory Tesz, 286223

Safety analysis of rFVIIa with emicizumab dosing in congenital hemophilia A with inhibitors: Experience from the HAVEN clinical program

ISTH Academy, Gallia Levy, 286224

Thrombin‐generating potential, plasma clot formation, and clot lysis are impaired in patients with bleeding of unknown cause

ISTH Academy, Johanna Gebhart, 286225

ISTH news and updates: Join the ISTH today

ISTH Academy, Faculty / Presenter(s), 286226

Response to Letter to the Editor submitted by Dr. Gando and Dr. Otomo re: Trauma‐induced coagulopathy: The past, present, and future

ISTH Academy, Naohito Inagaki, 286227

Termination of bleeding by a specific, anticatalytic antibody against plasmin

ISTH Academy, Maria Cristina Gottardi, 286228

What the Neighbors Say

ISTH Academy, Faculty / Presenter(s), 286229

Genomic momentum for hemostasis and thrombosis

ISTH Academy, Faculty / Presenter(s), 286230

Erratum

ISTH Academy, Faculty / Presenter(s), 286231

Issue Information

ISTH Academy, Faculty / Presenter(s), 286232

Cell surface expression of HLA I molecules as a marker of young platelets

ISTH Academy, Blandine Maître, 286233

Variability of von Willebrand factor‐related parameters in endothelial colony forming cells

ISTH Academy, Jeroen Eikenboom, 286234

Role of RXRβ in platelet function and arterial thrombosis

ISTH Academy, benjamin taisne, 286235

New insights into cytoskeletal remodeling during platelet production

ISTH Academy, Wolfgang Bergmeier, 286236

Trauma‐induced coagulopathy: The past, present, and future: A comment

ISTH Academy, Puja Soni, 286237

DIC in obstetrics: Diagnostic score, highlights in management, and international registry‐communication from the DIC and Women's Health SSCs of the International Society of Thrombosis and Haemostasis

ISTH Academy, Maha Othman, 286238

New treatment paradigm for hemophilia poses challenges for legacy bioassays

ISTH Academy, Steven Pipe, 286239

Predicting the risk of recurrent venous thrombosis: What the future might bring

ISTH Academy, Suzanne Cannegieter, 286240

Pass interference: Getting in the way of platelets

ISTH Academy, Anirban Sen Gupta, 286241

The association of genetic variants in the cholesteryl ester transfer protein gene with hemostatic factors and a first venous thrombosis

ISTH Academy, Elisabetta Gualtieri, 286242

How We Treat Female Teens : patients with bleeding disorders & patients on anticoagulant therapies

ISTH Academy, Loren D’Angelo and Marilyn Blumenstein, 261693

Resolving DOAC interference on aPTT, PT, and lupus anticoagulant testing by the use of activated carbon

ISTH Academy, Els Bailleul, 278059

Disseminated intravascular coagulation in cardiac arrest and resuscitation

ISTH Academy, Mattia Piredda, 278060

Emicizumab and thrombosis: The story so far

ISTH Academy, Michael Makris, 278061

Endogenous sex hormones and risk of venous thromboembolism in young women

ISTH Academy, Suzanne Cannegieter, 278062

Monitoring of blood coagulation with non‐contact drop oscillation rheometry

ISTH Academy, R. Glynn Holt, 278063

Thromboprophylaxis in pregnant women: For whom and which LMWH dosage? Reply

ISTH Academy, Claire Mclintock, 278064

Curated disease‐causing genes for bleeding, thrombotic, and platelet disorders: Communication from the SSC of the ISTH

ISTH Academy, Kathleen Freson, 278065

What the Neighbours Say

ISTH Academy, Faculty / Presenter(s), 278066

Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery: Comment

ISTH Academy, Wolfgang Miesbach, 278067

Assessment of the analytical performances and sample stability on ST Genesia system using the STG‐DrugScreen application

ISTH Academy, Jonathan Douxfils, 278068

Endothelial force awakens a mechanism of portal hypertension: It's a neutrophil extracellular trap!

ISTH Academy, Jim Luyendyk, 278069

Thromboprophylaxis in pregnant women: For whom and which LMWH dosage?

ISTH Academy, Bernard Tardy, 278071

Impact of prothrombotic genotypes on the association between family history of myocardial infarction and venous thromboembolism

ISTH Academy, Birgit Sm�brekke, 278072

Risk of thromboembolic and bleeding outcomes following hematological cancers: A Danish population‐based cohort study

ISTH Academy, Anne Kristine Engebretsen, 278073

Anticoagulation of cancer patients with non‐valvular atrial fibrillation receiving chemotherapy: Guidance from the SSC of the ISTH

ISTH Academy, Simon Noble, 278074

Method agreement analysis and interobserver reliability of the ISTH proposed definitions for effective hemostasis in the management of major bleeding: Methodological issues

ISTH Academy, Siamak Sabour, 278075

Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery: Reply

ISTH Academy, Flora Peyvandi, 278076

Prophylactic administration of glycoPEGylated factor IX provides protection and joint outcome superior to recombinant factor IX after induced joint bleeding

ISTH Academy, Carsten Ley, 278077

Association of complete blood count parameters, d‐dimer, and soluble P‐selectin with risk of arterial thromboembolism in patients with cancer

ISTH Academy, Cihan Ay, 278078

Issue Information

ISTH Academy, Faculty / Presenter(s), 278079

ISTH News and Updates: Join the ISTH Today

ISTH Academy, Faculty / Presenter(s), 278080

Toward standardization of assays measuring extracellular vesicle‐associated tissue factor activity

ISTH Academy, Johannes Thaler, 278081

Reply: Method agreement analysis and interobserver reliability of the ISTH proposed definitions for effective hemostasis in the management of major bleeding: Methodological issues

ISTH Academy, Rahat A. Abdoellakhan, 278082

Functional polymorphisms in the LDLR and pharmacokinetics of Factor VIII concentrates

ISTH Academy, Francesco Bernardi, 278083

Risk of recurrent venous thromboembolism after acute pulmonary embolism: Role of residual pulmonary obstruction and persistent right ventricular dysfunction. A meta‐analysis

ISTH Academy, Cecilia Becattini, 278084

Blood coagulation factor Va's key interactive residues and regions for prothrombinase assembly and prothrombin binding

ISTH Academy, Mettine Bos, 278085

Proposal of a two‐step process for the diagnosis of sepsis‐induced disseminated intravascular coagulation

ISTH Academy, Toshiaki Iba, 278087

von Willebrand factor in experimental malaria‐associated acute respiratory distress syndrome

ISTH Academy, Simon F. De Meyer, 278088

Pharmacokinetics of idarucizumab and its target dabigatran in patients requiring urgent reversal of the anticoagulant effect of dabigatran

ISTH Academy, Stephan Glund, 278089